LONDON (Reuters) - General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell therapies, novel anti-cancer treatments and vaccines.
from Reuters: Science News https://ift.tt/2ET9QMN
//
0 comments:
Post a Comment